Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Polyvalent-display-libraries

 C-pyrazole A.sub.2A receptor agonists
We claim: 1. A composition of matter having the formula: ##STR00032## 2. A method for stimulating ...


 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
Advantageously, the present invention provides E1 expressing cell lines that are stable, can be ...


 Method for investigating the condition of a bacterial suspension through frequency profile of electrical admittance
We claim: 1. A method of investigating the condition of a suspension of bacteria in a fluid medium, ...


 Apparatus and methods for electroporation and electrofusion
To achieve the objects of this invention, a method of electroporation of a first type of cells is ...


 Controlled electroporation and mass transfer across cell membranes
The present invention arises in part from the discovery that the onset and extent of ...


 Antisense oligonucleotide alkylphosphonothioates and arylphospohonothioates
In a first aspect, the invention provides a method for synthesizing oligonucleotides having ...


 Polymer controlled induced viscosity fiber system and uses thereof
OF THE INVENTION As used in this application: a. "glycemic index" (GI) is calculated by dividing ...


 Methods and compositions for expression of competent eukaryotic gene products
DNA constructions are provided comprising control elements derived from heat-shock genes associated ...


 Thymidine kinase mutants
Briefly stated, the present invention provides compositions and methods which utilize Herpesviridae ...


 Enzymatic nucleic acids containing 5'-and/or 3'-cap structures
We claim: 1. An enzymatic nucleic acid molecule comprising a 5'-cap structure, a 3'-cap structure, ...


 Polyvalent display libraries

Details
Inventors: Buechler, Joe; Valkirs, Gunars; Gray, Jeff;
Assignee: Biosite Diagnostics, Inc. (San Diego, CA)
Primary Examiner: Huff; Sheela
Assistant Examiner: Bansal; Geetha P.
Attorney, Agent or Firm: Townsend and Townsend and Crew LLP

The invention is directed to inter alia two related but self-sufficient improvements in conventional display methods. The first improvement provides methods of enriching conventional display libraries for members displaying more than one copy of a polypeptide prior to affinity screening of such libraries with a target of interest. These methods can achieve diverse populations in which the vast majority of members retaining full-length coding sequences encode polypeptides having specific affinity for the target. In a second aspect, the invention provides methods of subcloning nucleic acids encoding displayed polypeptides of enriched libraries from a display vector to an expression vector without the need for clonal isolation of individual members. These methods result in polyclonal libraries of antibodies and other polypeptides for use, e.g., as diagnostic or therapeutic reagents.

DETAILED DESCRIPTION I.
General The present invention is directed to inter alia two related but self-sufficient improvements in conventional display methods.
The first improvement provides methods of enriching conventional display libraries for members displaying more than one copy of a polypeptide prior to affinity screening of such libraries with a target of interest.
Although practice of the claimed methods is not dependent on an understanding of mechanism, the rationale for these methods is believed to be that affinity selection of library members to immobilized binding partners occurs predominantly or exclusively through formation of multivalent bonds between multiple copies of displayed polypeptides on a library member and immobilized binding partners.
Accordingly, only members of library displaying multiple copies of a polypeptide are capable of surviving affinity selection to immobilized binding partners.
For example, conventional libraries of polypeptides fused to pVIII or a filamentous phage typically have Poisson distribution, in which most members display no copies of a polypeptide, a small proportion display one copy of a polypeptides, a still smaller proportion display two copies, and a still smaller proportion display three or more copies.
The methods of the present invention enrich for the small proportion of conventional display libraries displaying two or more copies of a polypeptide.
It is this rare fraction of conventional libraries that is capable of being affinity selected by immobilized binding partners.
Enrichment can be achieved by the inclusion of a tag as a component of the fusion protein from which polypeptides are displayed.
The tag can be any polypeptide with a known receptor showing high binding specificity for the tag.
The same tag is included in each member of the library.
Enrichment is effected by screening the library for affinity binding to an immobilized receptor for the tag.
Only library members having two or more copies of the tag are capable of binding to the immobilized receptor



Related patents
  Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
OF THE INVENTION A. Definitions Amino Acid Residue: An amino acid formed upon chemical digestion (hydrolysis) of a polypeptide at its peptide linkages. The amino acid ...
  Pharmaceutical and diagnostic business systems and methods
Improved business methods, devices, and systems for utilizing genetic information are provided. According to one embodiment of the invention a business method is ...
  Addition compound of a nucleotide and an amino acid and the use thereof in protection against actinic radiation
I claim: 1. A topical composition for protection against actinic radiation, comprising a dermatologically acceptable inert carrier suitable for application to human skin,...
  Method of differential display of exposed mRNA by RT/PCR
We claim: 1. A method of comparing the presence or level of individual mRNA molecules in two or more nucleic acid samples, comprising the steps of: providing a first ...
  Methods of screening for compounds that derepress or increase telomerase activity
We claim: 1. Method for screening for a telomerase derepression agent, the method comprising the steps of: contacting a cell lacking telomerase activity with a potential ...
  Oral vaccines
What is claimed is: 1. A protein conjugate comprising an immunogen covalently linked to a carrier molecule, wherein said carrier molecule is capable of specifically ...
  Method for identifying validated target and assay combinations for drug development
The invention relates to methods that couple the validation of a target (see Definitions) for drug discovery with the development of an assay to identify compounds that ...
  Synthetic DNA sequences having enhanced expression in monocotyledonous plants and method for preparation thereof
OF THE PREFERRED EMBODIMENTS The following definitions are provided for clarity of the terms used in the description of this invention. "Rare monocotyledonous codons" ...
  Synthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
OF THE INVENTION The phosphonate internucleosidyl linkages used in oligomers of the present invention contain an lower alkyl group replacing one of the two non-bonding (...
  Sequence specific DNA binding by p53
It is an object of the invention to provide a method for detecting the presence of wild-type p53 protein in a cell. It is another object of the invention to provide a ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved